Hypomethylation-induced prognostic marker zinc finger DHHC-type palmitoyltransferase 12 contributes to glioblastoma progression
Unexpectedly, the mouse model overexpressing MET was able to counteract this resistance to immunotherapy, and the tumor's expansion was markedly reduced when the MET inhibitor was used alongside the anti-PD-1 antibody
K., Lysiuk, R., Antonyak, H., Noor, S., Akram, M., Smetanina, K., Piscopo, S., Upyr, T., & Peana, M
Protocol planning Peptide cycling requires planning reconstitution timing to align with protocol phases
Yoshida first isolated the purified enzyme from human RBCs in 1966
To date, ipamorelins efficacy has only been tested in one phase 2 clinical trial, which was a small, proof of concept study that involved just 114 participants [5]